Comments for ARXT - Stockpickr! Your Source for Stock Ideas

Comments for ARXT

Added By	Comments	Type	Date Added
SJones8573	Diversification and appreciation	Love	August 13, 2007
stockerblog	700 shares, 1 purchaser	Love	June 19, 2007
Barrons	"To hear some tell it, Adams Respiratory Therapeutics (ARXT) investors may have a bit more to worry about than the approaching end of cold-and-flu season -- a potential generic version of Adams' popular mucus thinner Mucinex." Adams has grown rapidly since it launched Mucinex, supported by its Mr. Mucus cartoon spokes-blob. Sales were $61 million in fiscal 2004 and are projected to hit $400 million in the year ending this June. But an application accepted by the Food and Drug Administration for a generic version of Mucinex by Pharmaceutical Holdings, Mutual Pharmaceutical and United Research Laboratories has remained largely off the Street's radar screens."	Hate	February 17, 2007